Thus, this lymphoma subtype has been extensively evaluated using the theranostics CXCR4 PET probe [68 Ga]Ga-PentixaFor to report on the current status of chemokine receptor expression (2–6). This evidence concerns the gene CXCR4 and lymphoma.